Bronchiolitis obliterans with organising pneumonia (BOOP) is a clinicopathological syndrome which has become increasingly recognised during the past decade. Several studies have been performed in larger collections of patients,'-10 and increasing numbers of case reports on the association of this syndrome with underlying conditions have been reported. " Clinically, the entity usually starts with a subacute influenza-like illness, followed by cough, progressive dyspnoea, and weight loss. Radiographically, the disease is characterised by multiple patchy alveolar infiltrates not responsive to antibiotics, and functionally by hypoxaemia and a restrictive ventilatory defect."' Histopathologically, buds ofgranulation tissue are focally seen in respiratory bronchioles and in alveolar ducts, with extension ofthe organisation into the alveoli (organising pneumonia). 412 The involvement of the bronchioles may sometimes be missed in biopsy samples, and the term "cryptogenic organising pneumonitis (COP)" may then be more appropriate. ' showing both bronchiolitis obliterans and organising pneumonia (BOOP cases), and 10 with lesions of bronchiolitis obliterans only but no parenchymal involvement. Of the 57 cases of BOOP, 50 were idiopathic (no underlying cause or disease), and seven were associated with causes or underlying conditions (two with inhalation injury, five with connective tissue disease). The merit of this study was to make clinicians and pathologists aware of this distinct entity within the spectrum of infiltrative lung diseases, to describe the clinical picture in detail, and to provide good arguments that idiopathic BOOP (which has been confused with idiopathic pulmonary fibrosis (IPF) or usual interstitial pneumonitis (UIP)) has a much better prognosis and that a clear distinction would be important.
However, idiopathic BOOP is not a new lesion and similar cases have been previously described under different synonyms -for example, bronchiolitis interstitial pneumonia (BIP) by Liebow and Carrington" in their classification of the chronic interstitial pneumonias, or cryptogenic organising pneumonia (COP) by Davison et al,'3 who were the first to recognise the association of the distinct clinical feature with the pathological lesion and also to report the dramatic response to prednisolone. As early as 1901, Lange'6 was the first to describe the histological changes of bronchiolitis obliterans in a necroscopic study of two patients. In retrospect, his histological description is more like BOOP than bronchiolitis obliterans. Causes BOOP may be idiopathic or associated with underlying conditions.l7AO Most cases of BOOP are idiopathic, but this clinicopathological syndrome has been described in association with many different factors, particularly collagen vascular disease and administration of drugs (box). In Epler's original series 50 of 57 cases (88%) were idiopathic, five were associated with connective tissue disorders, and two with acute inhalation injury. or azathioprine (n = 2). A weakness of this study is that it is unclear how the patients were selected. The methods section describes the study design poorly. The study population is said to comprise 10 patients with biopsy-proven BOOP who presented "with a fulminant course". No criteria for a fulminant course are given. In the introduction the authors say that they "describe 10 patients with rapidly progressive respiratory failure attributed to BOOP who progressed to death or end-stage lung disease". This is not quite correct since one Outcome of BOOP in previous studies Several larger retrospective series comprising more than 10 patients are available and can be analysed. In Epler's original series' the mean follow up period after biopsy of 48 patients with idiopathic BOOP was four years (range 2-10). Twenty nine (60%) showed complete recovery, five of them without steroid therapy; 13 (27%) were stabilised with some residual cough or dyspnoea; two (4%) had progressive disease and were alive; two died from BOOP and two from other causes (pulmonary embolism, ruptured aneurysm). The five patients with BOOP and connective tissue disorders fared worsenone recovered completely.
In Chandler et al's series2 of 24 cases (17 idiopathic, seven with collagen vascular disease) with a mean follow up of 3-5 years (range two months to eight years), nine patients (38%) recovered completely, seven (30%) recovered with residual disease, and three (12%) died from BOOP. In another paper by the same group, a worse course was described in those with collagen vascular disease 
SYMPTOMS AND SIGNS
It is clear that the period of symptoms before diagnosis must have been shorter in those selected as rapidly progressive patients with a mean of 6-5 weeks (range three days to two months) than in the historical "control" series with a mean of about three months (range two weeks to nine months). The symptoms and signs were similar, with cough, dyspnoea, fever, and crackles being present in most patients in most series.`'" Clubbing was seen in only-one of the 10 patients with rapidly progressive BOOP, as it is unusual in all studies contrasting BOOP with IPF. (19) 51 (27) Lymphocytes 44 (19) 41 (26) 23 (6) Neutrophils 10 (13) 4 (3) 14 (4) Eosinophils 6 (8) 3 (6) 5 (2) CD4ICD8 ratio 06 (0-5) 
